drugset / Trial / NCT00325715
AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers
RandomizedParallel-groupSingle-blindPrevention
Summary
AGN 201904, a proton pump inhibitor, versus esomeprazole in the prevention of stomach or upper intestinal damage following administration of high-dose aspirin in healthy volunteers
Timeline
- Start
- 2006-04
- Primary completion
- 2006-08
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AGN 201904 | Small molecule | — | — |
| Comparator | Esomeprazole | Small molecule | — | — |